Apple lobbies US to buy chips from blacklisted CXMT

The optics here are the story. Apple has spent the past year publicly backing US chip production, and just this week took the extreme step of raising prices on every Mac, iPad, home device and the Vision Pro - $100 to $500 per product, or roughly 17% to 25% across base configurations by Evercore's count ^[1][2]. Days later, the same company is reported to be lobbying the Commerce Department and the Trump administration for permission to source memory from CXMT, a firm the Pentagon flags for alleged ties to the People's Liberation Army ^[3]. Apple reportedly first approached Commerce more than a month ago and has since worked allies across Washington ^[4]. The throughline is not ideology but arithmetic: once component costs rose far enough that Apple could no longer absorb them, picking sides in the US-China chip standoff became a line item it was willing to renegotiate.

Apple's squeeze is a second-order effect of the AI buildout. Samsung, SK Hynix and Micron have redirected wafer capacity away from consumer DRAM toward high-bandwidth memory (HBM) for AI data centers, where margins are far richer ^[2]. With those fabs reallocated, commodity DRAM - the kind that goes into a MacBook or iPad - turned scarce, and prices have quadrupled over the past three quarters according to Counterpoint Research ^[3]. That reframes the CXMT bid: Apple is not chasing a Chinese bargain so much as fleeing a shortage manufactured inside its own incumbent supply base. The AI gold rush that lifts Micron's earnings is the same force inflating Apple's bill of materials, and CXMT happens to be one of the few makers still pointed at the commodity segment everyone else abandoned.

The intuitive read - Apple wants discount Chinese chips - is the part the signals push back on hardest. Community and analyst chatter notes CXMT's DDR5 pricing has converged toward Samsung, SK Hynix and Micron, so the appeal is supplier diversification and negotiating leverage in a shortage rather than a lower sticker. Two structural caveats blunt the threat narrative. First, CXMT makes commodity DRAM but not HBM, so analysts argue it poses little danger to Micron's high-margin growth engine and that the move says more about Apple's cost position than about Micron's competitive one ^[5]. Second, CXMT may lack the surplus capacity to export cheap memory at all, given US export controls constraining its expansion and equipment access ^[3]. A second source that is already capacity-constrained is worth more as a bargaining chip against existing vendors than as a volume replacement.

The mechanism Apple is fighting is precise. Being on the Pentagon's 1260H list signals alleged military ties but does not by itself block private commercial deals; the real kill switch is the Commerce Department's Entity List, which would impose licensing requirements that could sever CXMT as a supplier ^[3]. Apple is essentially asking for an advance guarantee that listing will not happen. There is a direct precedent: in 2022 Apple abandoned plans to buy NAND from another Chinese memory maker, YMTC, after Washington added it to a trade restriction list, and political pressure at the time was intense. The same fault line is reopening - House China Committee chair John Moolenaar has already called an Apple-CXMT deal a grave mistake that would help China dominate critical supply chains ^[4]. Reporting frames the administration's eventual answer as a broader test of US restrictions on Chinese chipmakers whose stakes reach well past Apple ^[6].